online-thrilokyavijaya-book-pdf-version-1

jika; fiak je,swx.
ff;%f,dalHúchd
344
o Nahas, G.G. 1981. Marijuana and sex. Medical Aspects Human Sexuality
15(12):30–39.
o Nathan P.J., O'Neill B.V., Napolitano A. & E.T. Bullmore. 2011.
Neuropsychiatric adverse effects of centrally acting antiobesity drugs. CNS
Neuroscience & Therapeutics 17:490–505.
o Nayar S.L. 1955. Vegetable insecticides. Bulletin of National Institute of
Science in India 4:137–145.
o Nicholson A.N., Turner C., Stone B.M. & P.J. Robson. 2004. Effect of
delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and earlymorning
behavior in young adults. Journal of Clinical Psychopharmacology
24(3):305–13.
o Ohno-Shosaku T., Tanimura A., Hashimotodani Y. & M. Kano. 2012.
Endocannabinoids and retrograde modulation of synaptic transmission.
Neuroscientist 18:119–132.
o O'Shaughnessy W.B. 1842. On the preparation of the Indian Hemp of
Gunjah (Cannabis indica): the effects on the animal system in health and their
utility in the treatment of tetanus and other convulsive diseases, Transactions
of the Medical and Physical Society of Bombay 8:421- 461.
o O’Shaughnessy W.B. 1843. On the preparations of the Indian hemp, or gunjah
(Cannabis indica). Their effects on the animal system in health, and their utility
in the treatment of tetanus and other convulsive diseases. Provincial Medical
Journal and Retrospectives of Medical Sciences 5:343–398.
o Pacher P. & G. Kunos. 2013. Modulating the endocannabinoid system in
human health and disease - successes and failures. Journal of Federation of
European Biochemical Societies 280:1918–1943.
o Pacher P. & R. Mechoulam. 2011. Is lipid signaling through cannabinoid 2
receptors part of a protective system? Progress in Lipid Research 50:193–
211.
o Park, B., McPartland J.M. & M. Glass. 2004. Cannabis, cannabinoids and
reproduction. Prostaglandins Leukotrienes and Essential Fatty Acids
70(2):189–197.
o Pasquariello N., Oddi S., Malaponti M. & M. Maccarrone. 2009. Regulation of
gene transcription and keratinocyte differentiation by anandamide. Vitamins
and Hormones 81:441–467.
o Pertwee R.G. 2009. Emerging strategies for exploiting cannabinoid receptor
agonists as medicines. British Journal of Pharmacology 156:397–411.
o Pertwee R.G. 2014. Elevating endocannabinoid levels: pharmacological
strategies and potential therapeutic applications. Proceedings of Nutrition
Society 73:96–105.
o Pertwee R.G. 2010. Receptors and channels targeted by synthetic cannabinoid
receptor agonists and antagonists. Current Medicinal Chemistry17:1360–1381.